Press "Enter" to skip to content

Why investors should be more worried about Lupin than DRL

Main focus area remains complex generics where other cos have an advantage

Original source: https://health.economictimes.indiatimes.com/news/pharma/why-investors-should-be-more-worried-about-lupin-than-drl/69443999?utm_source=RSS&utm_medium=ETRSS

Also Read:   Maharishi Ayurveda launches AyurDefence-AV